H.C. Wainwright Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $21

H.C. Wainwright analyst Joseph Pantginis maintains $PDS Biotechnology(PDSB.US)$ with a buy rating, and maintains the target price at $21.According to TipRanks data, the analyst has a success rate of 3

moomoo NewsJun 12 10:31 ET · Ratings

PDS Biotechnology Is Maintained at Buy by B. Riley Securities

PDS Biotechnology Is Maintained at Buy by B. Riley Securities

Dow JonesJun 12 10:25 ET

B.Riley Financial Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Cuts Target Price to $9

B.Riley Financial analyst Mayank Mamtani maintains $PDS Biotechnology(PDSB.US)$ with a buy rating, and adjusts the target price from $11 to $9.According to TipRanks data, the analyst has a success rat

moomoo NewsJun 12 08:33 ET · Ratings

B. Riley Lowers Price Target on PDS Biotechnology to $9 From $11, Maintains Buy Rating

PDS Biotechnology (PDSB) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $5 to $21.

MT NewswiresJun 12 08:01 ET

Express News | PDS Biotech Provides Data Update From Ongoing Versatile-002 Phase 2 Clinical Trial in Head and Neck Cancer

ReutersJun 12 08:00 ET

Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults

USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale...

PR NewswireMay 28 13:24 ET